India's Richest People 2026 edition · 1 director · Source: Hurun India
- #143 Mahima Datla & family ₹25,200 Cr
B E Immuno Sciences Private Limited
B E Immuno Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Active Private Limited Company pharma
Revenue · FY 2025
₹10.1 Lakh
▼ 56% YoY
Net profit · FY 2025
₹3.73 Lakh
Net margin 36.9%
EBITDA · FY 2025
₹9.27 Lakh
EBITDA margin 91.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹185 Cr
Satisfied ₹18.92 Lakh
Company age
27 yrs
Est. 1999
Directors on board
3
As per MCA filings
About B E Immuno Sciences Private Limited
Data last updated:
B E Immuno Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 May 1999 and has been in existence for over 27 years.
Its director Mahima Datla and family are #143 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1999PTC031761. Its GSTIN is 36AACCB7274Q1Z1 (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sridhar Pusapati Raju and Mahima Datla.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18/3 Azamabad, Hyderabad, Telangana, India – 500020.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.1 Lakh, a decline of 56% compared to the previous year. For the same year it recorded a net profit of ₹3.73 Lakh (net margin 36.9%) and EBITDA of ₹9.27 Lakh (EBITDA margin 91.8%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years.
As per MCA filings, the company has open charges of ₹185 Cr and satisfied charges of ₹18.92 Lakh on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230TG1999PTC031761
Registration Number 031761
Incorporation Date 24 May 1999
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
CIN history
B E Immuno Sciences has one previous CIN (Corporate Identification Number): U24230AP1999PTC031761. The current CIN is U24230TG1999PTC031761, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1999PTC031761 | Current |
| U24230AP1999PTC031761 | Previous |
Recognitions & Rankings of B E Immuno Sciences
Contact details
B E Immuno Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address18/3 Azamabad, Hyderabad, Telangana, India – 500020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of B E Immuno Sciences Private Limited, buy the company report.
Comprehensive company report
B E Immuno Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of B E Immuno Sciences Private Limited
FY 2025 filings availableB E Immuno Sciences Private Limited reported revenue of ₹10.1 Lakh (down 56% YoY) for FY 2025.
Revenue · FY 2025
₹10.1 Lakh ▼ 56%
Net profit · FY 2025
₹3.73 Lakh margin 36.9%
EBITDA · FY 2025
₹9.27 Lakh margin 91.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 56%
3 years · compounded
▼ 33%
EBITDA CAGR growth
1 year
▼ 56%
3 years · compounded
▲ 35%
Revenue has declined at a compounded annual rate (CAGR) of 33% over three years, including a 56% fall in the latest year. EBITDA fell 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 91.8% | ||||
| Net Profit Margin | 36.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of B E Immuno Sciences Private Limited, buy the company report.
Board of directors of B E Immuno Sciences Private Limited
B E Immuno Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sridhar Pusapati Raju | Director | 24 May 1999 | 27 Years 5 Months | Current |
| Mahima Datla | Director | 24 May 1999 | 27 Years 5 Months | Current |
| Mantena Purnima | Additional Director | 12 Apr 2013 | 13 Years 6 Months | Current |
Peer comparison
B E Immuno Sciences Private Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Real Estate Leasing), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Praveenraj Transport Private Limited | ₹10.15 Lakh (FY 2025) | 1.0% | Bikaner, Rajasthan, India | |||
| Olympus Packaging Private Limited | ₹10.14 Lakh (FY 2025) | -16.0% | Bhiwandi, Maharashtra, India | |||
| J S Nirman Pvt Ltd | ₹10.14 Lakh (FY 2025) | -29.0% | Kolkata, West Bengal, India | |||
| M S Switchgears Private Limited | ₹10.12 Lakh (FY 2025) | 0.0% | Nashik, Maharashtra, India | |||
| A.K.C.Services Private Limited | ₹10.11 Lakh (FY 2024) | 46.0% | Dehradun, Uttarakhand, India | |||
| B E Immuno Sciences Private Limitedthis company | ₹10.1 Lakh (FY 2025) | ₹3.73 Lakh | 36.9% | -56.0% | Hyderabad, Telangana, India | |
| Newtown Conclave Private Limited | ₹10.1 Lakh (FY 2023) | 11.0% | Kolkata, West Bengal, India | |||
| Framroz Apartments Pvt Ltd | ₹10.08 Lakh (FY 2022) | 35.0% | Mumbai, Maharashtra, India | |||
| Snehanjali Developers Private Limited | ₹10.08 Lakh (FY 2024) | 44.0% | Mumbai, Maharashtra, India | |||
| Burelax India Pvt Ltd | ₹10.08 Lakh (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Riverdale Academy Private Limited | ₹10.08 Lakh (FY 2025) | 252.0% | Kolkata, West Bengal, India |
To see the full peer comparison of B E Immuno Sciences Private Limited, buy the company report.
Auditor
B E Immuno Sciences Private Limited is audited by K RAGHUNATH & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K RAGHUNATH & CO | FY 2021 | 003341S |
Shareholding
The shareholding of B E Immuno Sciences Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of B E Immuno Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹185 Cr
Satisfied charges
₹18.92 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jun 2024 | 100956429 | Others | ₹185 Cr | Open | |
| 25 Nov 2011 | 10320893 | Panjab National Bank | ₹18.92 Lakh | Satisfied |
To see the full charge records of B E Immuno Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
B E Immuno Sciences Private Limited has 4 court cases on record: 1 filed by B E Immuno Sciences, 3 filed against it. All cases are disposed.
Total cases
4
Filed by the company
1
Filed against the company
3
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against State of Telangana | Disposed |
| District court, Hyderabad CCC, Telangana | Court case (T.R.O.P) | Filed against the company | Disposed |
| District court, Hyderabad CCC, Telangana | Petition | Filed against the company | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company | Disposed |
To see the full case history of B E Immuno Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for B E Immuno Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
B E Immuno Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCB7274Q1Z1 | Telangana | Active | 01 Aug 2020 |
To see the full GST registrations and return filing status of B E Immuno Sciences Private Limited, buy the company report.
Recent activity
B E Immuno Sciences Private Limited has 4 board changes on record since 1999: 3 appointments and 1 cessation. The latest: Mantena Purnima was appointed as Additional Director on 12 Apr 2013.
AGM
B E Immuno Sciences Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records.
Filing
B E Immuno Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others of Rs. 18,500.00 Lakh registered on 26 Jun 2024 with Charge ID 100956429 was modified on 07 Oct 2024.
Charges
A charge with Others amounted to Rs. 18,500.00 Lakh with Charge ID 100956429 was registered on 26 Jun 2024.
Charges
A charge registered on 25 Nov 2011 via Charge ID 10320893 with Panjab National Bank was fully satisfied on 28 Aug 2014.
Appointed
Mantena Purnima was appointed as Additional Director.
Ceased
Vijaykumar Datla ceased to be Director.
Charges
A charge with Panjab National Bank amounted to Rs. 18.92 Lakh with Charge ID 10320893 was registered on 25 Nov 2011.
Appointed
Mahima Datla was appointed as Director.
Appointed
Sridhar Pusapati Raju was appointed as Director.
Incorporation
24 May 1999
B E Immuno Sciences Private Limited was registered on 24 May 1999 with Roc Hyderabad & aged 27 years 5 months as per MCA records.
Frequently asked questions
B E Immuno Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 May 1999 (27+ years old) and is registered under CIN U24230TG1999PTC031761.
B E Immuno Sciences has 3 current directors:
- Sridhar Pusapati Raju - Director
- Mahima Datla - Director
- Mantena Purnima - Additional Director
The latest financial statements of B E Immuno Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of B E Immuno Sciences is 36AACCB7274Q1Z1, registered in Telangana.
The CIN (Corporate Identification Number) of B E Immuno Sciences is U24230TG1999PTC031761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
B E Immuno Sciences has 4 court cases on record: 1 filed by the company and 3 filed against it. Most are in the district courts.
B E Immuno Sciences was incorporated on 24 May 1999, making it 27+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of B E Immuno Sciences by revenue are Praveenraj Transport Private Limited, Olympus Packaging Private Limited, J S Nirman Pvt Ltd, M S Switchgears Private Limited, A.K.C.Services Private Limited and 5 more, all in the BFSI industry (Real Estate Leasing).
Mantena Purnima was appointed as Additional Director on 12 Apr 2013. Vijaykumar Datla ceased to be Director on 20 Mar 2013. Mahima Datla was appointed as Director on 24 May 1999. B E Immuno Sciences has 4 board changes on record in total.
The registered office of B E Immuno Sciences is at 183 Azamabad, Hyderabad, Telangana, India – 500020.
B E Immuno Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages